β-Carotene can reverse dysregulation of iron protein in an in vitro model of inflammation

Immunologic Research

Volumn 61, Issue 1-2, 2015, Pages 70-78

  Katz, Oksana ^a   Reifen, Ram ^a   Lerner, Aaron ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Caco 2; Inflammation; Iron; Iron metabolism; Carotene

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BETA CAROTENE; FERRITIN; FERROPORTIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; IRON; RETINOL; TRANSFERRIN RECEPTOR; CAROTENOID; CARRIER PROTEIN; CATION TRANSPORT PROTEIN; METAL TRANSPORTING PROTEIN 1; PROTEIN BINDING;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INTESTINE EPITHELIUM CELL; IRON ABSORPTION; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION; BIOSYNTHESIS; CACO 2 CELL LINE; DOSE RESPONSE; GENETICS; INTRACELLULAR SPACE; METABOLISM;

ANTI-INFLAMMATORY AGENTS; BETA CAROTENE; CACO-2 CELLS; CAROTENOIDS; CARRIER PROTEINS; CATION TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRITINS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-8; INTRACELLULAR SPACE; IRON; PROTEIN BINDING; RECEPTORS, TRANSFERRIN;

EID: 84925483360     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-014-8570-8     Document Type: Article

References (41)

1. Gangat N, Wolanskyi AP. Anemia of chronic disease. Semin Hematol. 2013;50:232–8.
2. Simpson RJ, McKie AT. Regulation of intestinal iron absorption: the mucosa takes control? Cell Metab. 2009;10:84–7.
3. Tandara L, Salamunic I. Iron metabolism: current and future directions. Biochem Medica. 2012;22:311–28.
4. Fleming KE, Ponka P. Iron overload in human disease. N Eng J Med. 2012;366(5):348–59.
5. During A, Albaugh G, Smith JC Jr. Characterization of b-Carotene 15,15′-dioxygenase activity in TC7 clone of human intestinal cell line Caco-2. Biochem Biophys Res Commun. 1998;249(2):467–74.
6. Alvarez-Hernandez X, Nichols GM, Glass J. Caco-2 cell line: a system for studying intestinal iron transport across epithelial cell monolayers. Biochim Biophys Acta. 1991;1070(1):205–8.
7. Bernotti S, et al. Inflammatory reaction without endogenous antioxidant response in Caco-2 cells exposed to iron/ascorbate-mediated lipid peroxidation. Am J Physiol Gastrointest Liver Physiol. 2003;285(5):G898–906.
8. He W, et al. Availability and toxicity of Fe(II) and Fe(III) in Caco-2 cells. J Zhejiang Univ Sci B. 2008;9(9):707–12.
9. Zödl B, et al. Toxicological effects of iron on intestinal cells. Cell Biochem Funct. 2004;22(3):143–7.
10. Eckmann L, et al. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology. 1993;105(6):1689–97.
11. Bestwick CS, Milne L. Effects of beta-carotene on antioxidant enzyme activity, intracellular reactive oxygen and membrane integrity within post confluent Caco-2 intestinal cells. Biochim Biophys Acta. 2000;1474(1):47–55.
12. Zold B, et al. Ascorbic acid mediated iron toxicity in Caco-2 cells: effects of different iron species. Cell Membr Free Radic Res. 2010;2(2):92–7.
13. Orino K, et al. Ferritin and the response to oxidative stress. Biochem J. 2001;357:241–7.
14. Repetto G, Del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc. 2008;3(7):1125–31.
15. Kruger NJ. The Bradford method for protein quantitation. Methods Mol Biol. 1994;32:9–15.
16. Piñero DJ, et al. Interleukin-1 beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool. Biochim Biophys Acta. 2000;1497:279–88.
17. Rogers JT, et al. Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1. J Biol Chem. 1990;265:14572–8.
18. Grygas J, et al. Hepatocyte growth factor enhances IL-1β stimulated IL-8 secretion by Caco-2 epithelial cells. Vitro Cell Dev Biol Animal. 2007;43(3–4):147–52.
19. Jurado RL. Iron, infections, and anemia of inflammation. Clin Infect Dis. 1997;25(4):888–95.
20. Zamboni P. The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med. 2006;99(11):589–93.
21. Uritski RI, et al. Dietary iron affects inflammatory status in a rat model of colitis. J Nutr. 2004;134(9):2251–5.
22. Núñez MT, et al. Iron-induced oxidative damage in colon carcinoma (Caco-2) cells. Free Radic Res. 2001;34(1):57–68.
23. Yamamoto K, et al. Combined effect of hydrogen peroxide induced oxidative stress and IL-1 alpha on IL-8 production in CaCo-2 cells (a human colon carcinoma cell line) and normal intestinal epithelial cells. Inflammation. 2003;27(3):123–8.
24. Ivison SM, et al. Oxidative stress enhances IL-8 and inhibits CCL20 production from intestinal epithelial cells in response to bacterial flagellin. Am J Physiol Gastrointest Liver Physiol. 2010;299(3):G733–41.
25. Rucker P, Torti FM, Torti SV. Role of H and L Subunits in mouse ferritin. J Biol Chem. 1996;271:33352–7.
26. Harrison PM. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta. 1996;1275:161–203.
27. Zoller H, et al. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology.2001;120(6):1412–9.
28. Martini LA, et al. Iron treatment downregulates DMT1 and IREG1 mRNA expression in Caco-2 cells. J Nutr. 2002;1(4):693–6.
29. Yang F, et al. Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J Biol Chem. 2002;277(42):39786–91.
30. Theurl I, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009;113:5277–86.
31. Burpee T, et al. Intestinal ferroportin expression in pediatric Crohn’s disease. Inflamm Bowel Dis. 2011;17(2):524–31.
32. Sukumaran A, et al. Effects of acute and chronic inflammation on proteins involved in duodenal iron absorption in mice: a time-course study. Br J Nutr. 2012;108(11):1994–2001.
33. Sukumaran A, et al. Expression of iron-related proteins in the duodenum is up-regulated in patients with chronic inflammatory disorders. Br J Nutr. 2014;111:1059–68.
34. Citelli M, et al. Vitamin A modulates the expression of genes involved in iron bioavailability. Biol Trace Elem Res. 2012;149;64–70.
35. Reifen R. Vitamin A as an anti-inflammatory agent. Proc Nutr Soc. 2002;61(3):397–400.
36. García-Casal MN, et al. Vitamin A and beta-carotene can improve nonheme iron absorption from rice, wheat and corn by humans. J Nutr. 1998;128:646–50.
37. Layrisse M, et al. New property of vitamin A and beta-carotene on human iron absorption: effect on phytate and polyphenols as inhibitors of iron absorption. Arch Latinoam Nutr. 2000;50:243–8.
38. García-Casal MN, Leets I. Carotenoids, but not vitamin A, improve iron uptake and ferritin synthesis by Caco-2 cells from ferrous fumarate and NaFe-EDTA. J Food Sci. 2014;79:H706–12.
39. Walczyk T, et al. No enhancing effect of vitamin A on iron absorption in humans. Am J Clin Nutr. 2003;77:144–9.
40. Dekker M. Carotenoids as scavengers of active oxygen species. In: Cadenas E, Packer L, editors. Handbook of antioxidants. Los Angeles: University of Southern California; 1996. p. 259–313.
41. Martin KR, Failla L, Smith JC. Beta-carotene and lutein protect HepG2 human liver cells against oxidant induced damage. J Nutr. 1996;126(9):2098–106.